BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Moodys
Novartis
Farmers Insurance
Argus Health
QuintilesIMS
Federal Trade Commission
Colorcon
Merck

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,900,554

« Back to Dashboard

Summary for Patent: 8,900,554
Title:Foamable composition and uses thereof
Abstract: The present invention provides a safe and effective insecticide composition suitable for treating a subject infested with a parasitic anthropode or to prevent infestation by an arthropod. The insecticide composition is a foamable composition, including a first insecticide; at least one organic carrier selected from a hydrophobic organic carrier, a polar solvent, an emollient and mixtures thereof, at a concentration of about 2% to about 5%, or about 5% to about 10%; or about 10% to about 20%; or about 20% to about 50% by weight; about 0.1% to about 5% by weight of a surface-active agent; about 0.01% to about 5% by weight of at least one polymeric agent selected from a bioadhesive agent, a gelling agent, a film forming agent and a phase change agent; and (5) a liquefied or compressed gas propellant at a concentration of about 3% to about 25% by weight of the total composition.
Inventor(s): Tamarkin; Dov (Maccbim, IL), Friedman; Doron (Karmei Yosef, IL), Eini; Meir (Ness Ziona, IL)
Assignee: Foamix Pharmaceuticals Ltd. (Rehovot, IL)
Application Number:13/400,330
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 8,900,554

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare FINACEA azelaic acid AEROSOL, FOAM;TOPICAL 207071-001 Jul 29, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,900,554

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,820,145 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
8,486,374 Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses ➤ Subscribe
8,840,869 Body cavity foams ➤ Subscribe
2,010,040,561 ➤ Subscribe
9,211,259 Antibiotic kit and composition and uses thereof ➤ Subscribe
9,050,253 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
8,119,150 Non-flammable insecticide composition and uses thereof ➤ Subscribe
8,722,021 Foamable carriers ➤ Subscribe
8,703,105 Oleaginous pharmaceutical and cosmetic foam ➤ Subscribe
8,486,376 Moisturizing foam containing lanolin ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,900,554

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1856294 ➤ Subscribe
China 101267804 ➤ Subscribe
Cyprus 1115989 ➤ Subscribe
Denmark 2494959 ➤ Subscribe
European Patent Office 1556009 ➤ Subscribe
European Patent Office 1663148 ➤ Subscribe
European Patent Office 1670435 ➤ Subscribe
European Patent Office 1699433 ➤ Subscribe
European Patent Office 1768648 ➤ Subscribe
European Patent Office 1863447 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Julphar
Fish and Richardson
Mallinckrodt
McKinsey
Dow
Covington
Healthtrust
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot